PDF herunterladen
Klin Padiatr 2017; 229(05): 286-292
DOI: 10.1055/s-0043-104220
Original Article
© Georg Thieme Verlag KG Stuttgart · New York

Assessment of Early Cardiovascular Risk in Children and Adolescents with Essential Hypertension

Bewertung des kardiovaskulären Risikos bei Kindern und Jugendlichen mit essentieller Hypertonie
Andreja Stelcar
1   Pediatrics, Univerzitetni Klinicni Center Maribor, Maribor, Slovenia
,
Evgenija Homsak
2   Department of Laboratory Diagnostics, Univerzitetni Klinicni Center Maribor, Maribor, Slovenia
,
Natasa Marcun Varda
1   Pediatrics, Univerzitetni Klinicni Center Maribor, Maribor, Slovenia
› Institutsangaben
Weitere Informationen

Publikationsverlauf

Publikationsdatum:
24. April 2017 (online)

Auch verfügbar auf
   Lizenzen und Reprints

Abstract

Objectives

The aim of our study was to investigate some early markers of hypertensive target organ damage in hypertensive children and adolescents, and to detect those showing most prominent clinical significance.

Methods

We included 100 children with essential hypertension (EH) and 50 age-matched healthy control children, and evaluated left ventricular mass (LVM), intima-media thickness in the carotid arteries (IMT), pulse wave velocity (PWV), microalbuminuria, biochemical parameters and some adipokines.

Results

Statistically significant differences between the 2 groups were observed for HDL-cholesterol, LDL-cholesterol, triglycerides, insulin, uric acid, glucose, apolipoprotein A1, and total adiponectin. The mean values of IMT, PWV and LVM were greater in hypertensive children, but only the differences in IMT and LVM were statistically significant. In addition, hypertensive children showed significantly higher values of AoSP (aortic systolic pressure), AoPP (aortic pulse pressure) and AIx@75 (augmentation index corrected for heart rate of 75 b.p.m.). Metabolic syndrome was diagnosed in 31% of hypertensive children.

Conclusions

A significant number of children with EH have early target organ changes as well as other risk factors, including metabolic syndrome, especially obese ones. However, IMT, LVM and some parameters of arterial stiffness have been found to be early markers in both obese and non-obese hypertensives. In addition, adipokines and coagulation factors seem to be important in obese hypertensives.

Zusammenfassung

Hintergrund

Das Ziel unserer Studie war es, einige frühe Zeichen hypertensiver Endorganschäden bei Kindern und Jugendlichen mit arterieller Hypertonie zu ermitteln um diejenigen zu finden, die klinisch am bedeutsamsten sind.

Patienten

Wir haben 100 Kinder und Jugendliche mit essentieller Hypertonie (EH) und 50 gleichaltrige gesunde Kinder und Jugendliche als Kontrollen in die Studie einbezogen.

Methoden

Die Studie beurteilte die linksventrikuläre Hypertrophie (LVM), die Intima Media Dicke der inneren Halsschlagader (IMT), die Pulswellengeschwindigkeit (PWV), Mikroalbuminurie, einige biochemische Parameter und Adipokine.

Ergebnisse

Zwischen den 2 Gruppen fanden wir statistisch signifikante Unterschiede für das HDL-Cholesterin, LDL-Cholesterin, die Triglyceride, das Insulin, die Harnsäure, den Blutzucker, das Aplipoprotein A1 und das Gesamt-Adiponectin. Die Mittelwerte (Durchschnittswerte) von IMT, PWV und LVM waren höher bei hypertensiven Kindern, aber nur die Unterschiede von IMT und LVM waren statistisch bedeutsam. Außerdem zeigten die hypertensiven Kinder signifikant höhere Werte vom AoSP (systolischer Druck in der Aorta), AoPP(Pulsdruck in der Aorta), und Alx@75 (Augmentations-Index adaptiert an die Herzfrequenz von 75/min). Das metabolische Syndrom haben wir bei 31% der hypertensiven Kinder diagnostiziert.

Schlussfolgerung

Eine signifikante Anzahl von Kindern mit EH, insbesondere die Übergewichtigen, haben frühe Endorganschäden sowie auch andere Risikofaktoren einschließlich des Metabolischen Syndroms. Allerdings haben sich IMT, LVM und einige Parameter der Arteriensteifigkeit als frühe Zeichen in beiden Gruppen, sowohl bei den Übergewichtigen, als auch bei Kindern mit Normalgewicht, erwiesen. Des Weiteren scheinen bei hypertensiven Übergewichtigen Adipokine und Gerinnungsfaktoren von Bedeutung zu sein.

Key words

adipokines - essential hypertension - intima-media thickness - left ventricular hypertrophy - pulse wave velocity

Schlüsselwörter

Adipokine - essentielle Hypertonie - Intima-Media-Dicke - linksventrikuläre Hypertrophie - Pulswellengeschwindigkeit
 

  • References

  • 1 Acosta AA, Samuels JA, Portman RJ. et al. Prevalence of persistent prehypertension in adolescents. J Pediatr 2012; 160: 757-761
    CrossrefPubMedGoogle Scholar
  • 2 Antoniewicz J, Litwin M, Daszkoska J. et al. Target organ damage in children with newly diagnosed and untreated essential hypertension. Przegl Lek 2006; 63: 101-106
    PubMedGoogle Scholar
  • 3 Asferg C, Mogelvang R, Flyvbjerg A. et al. Leptin, not adiponectin predicts hypertension in the Copenhagen city heart study. Am J Hypertens 2010; 23: 327-333
    CrossrefPubMedGoogle Scholar
  • 4 Assadi F. Effect of microalbuminuria lowering on regression of left ventricular hypertrophy in children and adolescents with essential hypertension. Pediatr Cardiol 2007; 28: 27-33
    CrossrefPubMedGoogle Scholar
  • 5 Berenson GS. Childhood risk factors predict adult risk associated with subclinical cardiovascular disease: The Bogalusa Heart Study. Am J Cardiol 2002; 90 (Suppl. 10) S3-S7
    PubMedGoogle Scholar
  • 6 Berthod HK, Giannakidou E, Krone W. et al. Influence of ghrelin gene polymorphisms on hypertension and atherosclerotic disease. Hypertens Res 2010; 33: 155-160
    CrossrefPubMedGoogle Scholar
  • 7 Boutouyrie P, Pannier B. Measurement of arterial stiffness. In: Laurent, ed. Central aortic blood pressure. Paris: Elsevier; 2008: 41-47
    Google Scholar
  • 8 Daniels SR, Loggie JMH, Khoury P. et al. Left ventricular geometry and severe left ventricular hypertrophy in children and adolescents with essential hypertension. Circulation 1998; 97: 1907-1911
    CrossrefPubMedGoogle Scholar
  • 9 Davis PH, Dawson JD, Riley WA. et al. Carotid intimal-medial thickness is related to cardiovascular risk factors measured from childhood through middle age. The Muscatine study. Circulation 2001; 104: 2815-2819
    CrossrefPubMedGoogle Scholar
  • 10 deSimone G, Daniels SR, Deveraux RB. et al. Left ventricular mass and body size in normotensive children and adults: Assessment of allometric relation. J Am Coll Cardiol 1992; 20: 1251-1260
    CrossrefPubMedGoogle Scholar
  • 11 Feig DI. Hyperuricemia in childhood primary hypertension. Hypertension 2003; 42: 247-252
    CrossrefPubMedGoogle Scholar
  • 12 Flynn J. The changing face of pediatric hypertension in the era of the childhood obesity epidemic. Pediatr Nephrol 2013; 28: 1059-1066
    CrossrefPubMedGoogle Scholar
  • 13 Glowinska B, Urban M, Koput A. et al. Selected new atherosclerosis risk factors and markers of fibrinolysis in children and adolescents with obesity, hypertension and diabetes. Przgl Lek 2003; 60: 12-17
    PubMedGoogle Scholar
  • 14 Gonzalez Jaunatey JR, Paz FL, Eiras S. et al. Adipokines as novel cardiovascular disease markers. Pathological and clinical considerations. Rev Esp Cardiol 2009; 62: 9-16
    CrossrefPubMedGoogle Scholar
  • 15 Khoury PR, Mitsnefes M, Daniels SR. et al. Age-specific reference intervals for indexed left ventricular mass in children. J Am Soc Echogardiogr 2009; 22: 709-714
    PubMedGoogle Scholar
  • 16 Landin K, Tengborn L, Smith U. Elevated fibrinogen and plasminogen activator inhibitor (PAI-1) in hypertension are related to metabolic risk factors for cardiovascular disease. J Intern Med 1990; 227: 273-278
    CrossrefPubMedGoogle Scholar
  • 17 Litwin M, Michalkiewicz J, Gackowska L. Primary hypertension in children and adolescents is an immuno-metabolic disease with hemodynamic consequences. Curr Hypertens Rep 2013; 15: 331-339
    CrossrefPubMedGoogle Scholar
  • 18 Litwin M, Niemirska A, Sladowska J. et al. Left ventricular hypertrophy and arterial wall thickening in children with essential hypertension. Pediatr Nephrol 2006; 21: 811-819
    CrossrefPubMedGoogle Scholar
  • 19 Litwin M, Sladowska J, Syczewska M. et al. Different BMI cardiovascular risk thresholds as marker of organ damage and metabolic syndrome in primary hypertension. Pediatr Nephrol 2008; 23: 787-796
    CrossrefPubMedGoogle Scholar
  • 20 Litwin M, Trelewicz J, Wawer Z. et al. Intima-media thickness and arterial elasticity in hypertensive children: Controlled study. Pediatr Nephrol 2004; 19: 767-774
    CrossrefPubMedGoogle Scholar
  • 21 Loncar R, Hrboka V, Tabakovic Loncar V. et al. Screening of plasma homocysteine in peripheral arterial disease. Ann Med 2001; 33: 48-54
    CrossrefPubMedGoogle Scholar
  • 22 Marčun Varda N, Gregorič A. A diagnostic approach for the child with hypertension. Pediatr Nephrol 2005; 20: 499-506
    CrossrefPubMedGoogle Scholar
  • 23 National High Blood Pressure Education Program Working Group on High blood pressure in Children and Adolescents . The Fourth Report on the Diagnosis, Evaluation, and Treatment of High Blood Pressure in Children and Adolescents. Pediatrics 2004; 144: 555-576
    CrossrefPubMedGoogle Scholar
  • 24 Pignoli P, Tremoli E, Poli A. et al. Intimal plus medial thickness of arterial wall: A direct measurement with ultrasound imaging. Circulation 1986; 74: 1399-1406
    CrossrefPubMedGoogle Scholar
  • 25 Poeykkoe SM, Kellokoski E, Hoerkkoe S. et al. Low plasma ghrelin is associated with insulin resistance, hypertension, and the prevalence of type 2 diabetes. Diabetes 2003; 52: 2546-2553
    CrossrefPubMedGoogle Scholar
  • 26 Reusz GS, Cseprekal O, Temmar M. et al. Reference values of pulse wave velocity in healthy children and teenagers. Hypertension 2010; 56: 217-224
    CrossrefPubMedGoogle Scholar
  • 27 Safar ME. Systolic blood pressure, pulse pressure and arterial stiffness as cardiovascular risk factors. Curr Opin Nephrol Hypertens 2001; 10: 257-261
    CrossrefPubMedGoogle Scholar
  • 28 Soergl M, Kirschstein M, Busch C. et al. Oscillometric twenty-four-hour ambulatory blood pressure values in healthy children and adolescents: a multicenter trial including 1141 subjects. J Pediatr 1997; 130: 178-184
    CrossrefPubMedGoogle Scholar
  • 29 Staessen JA, Wang J, Bianchi G. et al. Essential hypertension. Lancet 2003; 361: 1629-1641
    CrossrefPubMedGoogle Scholar
  • 30 Urbina EM, Williams RV, Alpert BS. Noninvasive assessment of subclinical atherosclerosis in children and adolescents. Hypertension 2009; 54: 919-950
    CrossrefPubMedGoogle Scholar